microRNAs and response to statins in patients with hypercholesterolemia: from basic research to precision medicine

Pharmacogenomics. 2018 Jun 1;19(9):748-751. doi: 10.2217/pgs-2018-0051. Epub 2018 May 22.

Authors

Tomás Zambrano^{1

2}, Luis A Salazar¹

Affiliations

¹ Center of Molecular Biology & Pharmacogenetics, Scientific & Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile.
² Department of Medical Technology, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

PMID: 29785870
DOI: 10.2217/pgs-2018-0051

No abstract available

Keywords: hypercholesterolemia; microRNAs; personalized medicine; pharmacoepigenetics; pharmacogenomics; statins.

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / drug therapy*
Hypercholesterolemia / genetics*
MicroRNAs / genetics*
Pharmacogenetics / methods
Precision Medicine / methods

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
MicroRNAs